SCHEMBL24048258

SCHEMBL24048258

c1ccc(-c2ccccc2N(c2ccccc2)c2cc(N(c3ccccc3)c3ccccc3-c3ccccc3)c3oc4ccc5ccccc5c4c3c2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 4/20 0.39
CYP1A1 P04798 4/20 0.39
CYP1A2 P05177 4/20 0.39
AHR P35869 3/20 0.39
PAX8 Q06710 2/20 0.39
FYN P06241 1/20 0.39
MAPK3 P27361 1/20 0.39
MAPT P10636 4/20 0.34
KMT2A Q03164 3/20 0.34
MEN1 O00255 2/20 0.34
TP53 P04637 2/20 0.34
CYP3A4 P08684 2/20 0.34
CYP2D6 P10635 2/20 0.34
CYP2C9 P11712 2/20 0.34
CYP2C19 P33261 2/20 0.34
KDM4E B2RXH2 4/20 0.33
ALDH1A1 P00352 3/20 0.32
HPGD P15428 3/20 0.32
TSHR P16473 2/20 0.32
HSD17B10 Q99714 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24048088 0.98 ABCG2 (0.39) ABCG2CYP1A1CYP1A2AHRPAX8
SCHEMBL24907739 0.96 ABCG2 (0.38) ABCG2CYP1A1CYP1A2AHRPAX8
SCHEMBL24907735 0.96 ABCG2 (0.38) ABCG2CYP1A1CYP1A2AHRPAX8
SCHEMBL24907734 0.95 ABCG2 (0.37) ABCG2CYP1A1CYP1A2AHRPAX8
SCHEMBL24907733 0.94 ABCG2 (0.38) ABCG2CYP1A1CYP1A2AHRPAX8
SCHEMBL24907729 0.93 ABCG2 (0.38) ABCG2CYP1A1CYP1A2AHRPAX8
SCHEMBL24047932 0.93 ABCG2 (0.36) ABCG2CYP1A1CYP1A2AHRPAX8
SCHEMBL24047943 0.93 ABCG2 (0.36) ABCG2CYP1A1CYP1A2AHRPAX8
SCHEMBL24907732 0.92 ABCG2 (0.35) ABCG2CYP1A1CYP1A2AHRPAX8
SCHEMBL24907730 0.92 ABCG2 (0.35) ABCG2CYP1A1CYP1A2AHRPAX8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230337531-A1 NOVEL COMPOUNDS AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME LG CHEM, LTD. (KR) 2023-10-19 US disclosed
US-20230337531-A1 NOVEL COMPOUNDS AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME LG CHEM, LTD. (KR) 2023-10-19 US disclosed
WO-2023003436-A1 ORGANIC LIGHT-EMITTING DEVICE 주식회사 엘지화학 2023-01-26 WO disclosed
WO-2021261977-A1 ORGANIC LIGHT-EMITTING DEVICE 주식회사 엘지화학 2021-12-30 WO disclosed
WO-2021235830-A1 NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME 주식회사 엘지화학 2021-11-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230337531-A1 NOVEL COMPOUNDS AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME CRY1, AHR, CRY2 ABCG2 2570/4885CYP1A1 21/4885CYP1A2 127/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.